Serum Levels of Anticyclic Citrullinated Peptide Antibodies, Interleukin-6, Tumor Necrosis Factor-α, and C-Reactive Protein Are Associated with Increased Carotid Intima-Media Thickness: A Cross-Sectional Analysis of a Cohort of Rheumatoid Arthritis Patients without Cardiovascular Risk Factors

Abstract EN

The main cause of death in rheumatoid arthritis (RA) is cardiovascular events.

We evaluated the relationship of anticyclic citrullinated peptide (anti-CCP) antibody levels with increased carotid intima-media thickness (cIMT) in RA patients.

Methods.

Forty-five anti-CCP positive and 37 anti-CCP negative RA patients, and 62 healthy controls (HC) were studied.

All groups were assessed for atherogenic index of plasma (AIP) and cIMT.

Anti-CCP, C-reactive protein (CRP), and levels of tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6) were measured by enzyme-linked immunosorbent assay (ELISA).

Results.

The anti-CCP positive RA patients showed increased cIMT compared to HC and anti-CCP negative (P<0.001).

Anti-CCP positive versus anti-CCP negative RA patients, had increased AIP, TNFα and IL-6 (P<0.01), and lower levels of high density lipoprotein cholesterol (HDL-c) (P=0.02).

The cIMT correlated with levels of anti-CCP (r=0.513, P=0.001), CRP (r=0.799, P<0.001), TNFα (r=0.642, P=0.001), and IL-6 (r=0.751, P<0.001).

In multiple regression analysis, cIMT was associated with CRP (P<0.001) and anti-CCP levels (P=0.03).

Conclusions.

Levels of anti-CCP and CRP are associated with increased cIMT and cardiovascular risk supporting a clinical role of the measurement of cIMT in RA in predicting and preventing cardiovascular events.